Person

Karen Drexler

Director, ResMed

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$226K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Apr 29, 2024RMDSale425$214.92$91K
Feb 2, 2023RMDSale594$226.58$135K

SEC reporting-owner ID (CIK) 1504699 · all filings on EDGAR